Scientists have demonstrated that two small, stable antibody variants derived from the South American mammals llamas can neutralise the novel coronavirus in lab-cultured cells, an advance which may lead to the development of new therapeutics against Covid-19.
The study, published in the journal Nature Structural & Molecular Biology, noted that the 'nanobodies' can prevent infection with the novel coronavirus SARS-CoV-2 by blocking its interaction with the protein ACE2, which it uses as a gateway to enter and infect cells.
According to the scientists, including those from The Rosalind Franklin Institute in the UK, passive immunisation, which involves giving a patient